Your browser doesn't support javascript.
loading
Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions.
Nasrallah, Ilya M; Pajewski, Nicholas M; Auchus, Alexander P; Chelune, Gordon; Cheung, Alfred K; Cleveland, Maryjo L; Coker, Laura H; Crowe, Michael G; Cushman, William C; Cutler, Jeffrey A; Davatzikos, Christos; Desiderio, Lisa; Doshi, Jimit; Erus, Guray; Fine, Larry J; Gaussoin, Sarah A; Harris, Darrin; Johnson, Karen C; Kimmel, Paul L; Kurella Tamura, Manjula; Launer, Lenore J; Lerner, Alan J; Lewis, Cora E; Martindale-Adams, Jennifer; Moy, Claudia S; Nichols, Linda O; Oparil, Suzanne; Ogrocki, Paula K; Rahman, Mahboob; Rapp, Stephen R; Reboussin, David M; Rocco, Michael V; Sachs, Bonnie C; Sink, Kaycee M; Still, Carolyn H; Supiano, Mark A; Snyder, Joni K; Wadley, Virginia G; Walker, Jennifer; Weiner, Daniel E; Whelton, Paul K; Wilson, Valerie M; Woolard, Nancy; Wright, Jackson T; Wright, Clinton B; Williamson, Jeff D; Bryan, R Nick.
  • Nasrallah IM; Department of Radiology, University of Pennsylvania, Philadelphia.
  • Pajewski NM; Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Auchus AP; Department of Neurology, University of Mississippi Medical Center, Jackson.
  • Chelune G; Department of Neurology, University of Utah School of Medicine, Salt Lake City.
  • Cheung AK; Division of Nephrology and Hypertension, University of Utah School of Medicine, Salt Lake City.
  • Cleveland ML; Section of Gerontology and Geriatric Medicine, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Coker LH; Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Crowe MG; Department of Psychology, University of Alabama at Birmingham.
  • Cushman WC; Preventive Medicine Section, Veterans Affairs Medical Center, Memphis, Tennessee.
  • Cutler JA; Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, Maryland.
  • Davatzikos C; Department of Radiology, University of Pennsylvania, Philadelphia.
  • Desiderio L; Department of Radiology, University of Pennsylvania, Philadelphia.
  • Doshi J; Department of Radiology, University of Pennsylvania, Philadelphia.
  • Erus G; Department of Radiology, University of Pennsylvania, Philadelphia.
  • Fine LJ; Clinical Applications and Prevention Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland.
  • Gaussoin SA; Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Harris D; Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Johnson KC; Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis.
  • Kimmel PL; Division of Kidney, Urologic, and Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Disorders, Bethesda, Maryland.
  • Kurella Tamura M; Division of Nephrology, Stanford University School of Medicine, Palo Alto, California.
  • Launer LJ; Neuroepidemiology Section, Intramural Research Program, National Institute on Aging, Bethesda, Maryland.
  • Lerner AJ; Department of Neurology, Case Western Reserve University School of Medicine, Cleveland, Ohio.
  • Lewis CE; Department of Epidemiology, University of Alabama at Birmingham.
  • Martindale-Adams J; Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis.
  • Moy CS; National Institute of Neurological Disorders and Stroke, Bethesda, Maryland.
  • Nichols LO; Preventive Medicine Section, Veterans Affairs Medical Center, Memphis, Tennessee.
  • Oparil S; Department of Medicine, University of Alabama at Birmingham.
  • Ogrocki PK; Department of Neurology, Case Western Reserve University School of Medicine, Cleveland, Ohio.
  • Rahman M; Department of Medicine, Louis Stokes Cleveland Veterans Affairs Medical Center, Case Western Reserve University, Cleveland, Ohio.
  • Rapp SR; Department of Psychiatry and Behavioral Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Reboussin DM; Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Rocco MV; Section of Nephrology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Sachs BC; Department of Neurology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Sink KM; Section of Gerontology and Geriatric Medicine, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Still CH; Now with Genentech, South San Francisco, California.
  • Supiano MA; Frances Payne Bolton School of Nursing, Case Western Reserve University, Cleveland, Ohio.
  • Snyder JK; Division of Geriatrics, University of Utah School of Medicine, Salt Lake City.
  • Wadley VG; Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, Maryland.
  • Walker J; Department of Medicine, University of Alabama at Birmingham.
  • Weiner DE; Section of Gerontology and Geriatric Medicine, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Whelton PK; Division of Nephrology, Tufts Medical Center, Boston, Massachusetts.
  • Wilson VM; Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana.
  • Woolard N; Section of Gerontology and Geriatric Medicine, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Wright JT; Section of Gerontology and Geriatric Medicine, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Wright CB; Division of Nephrology and Hypertension, Department of Medicine, Case Western Reserve University, Cleveland, Ohio.
  • Williamson JD; National Institute of Neurological Disorders and Stroke, Bethesda, Maryland.
  • Bryan RN; Section of Gerontology and Geriatric Medicine, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina.
JAMA ; 322(6): 524-534, 2019 08 13.
Article en En | MEDLINE | ID: mdl-31408137
ABSTRACT
Importance The effect of intensive blood pressure lowering on brain health remains uncertain.

Objective:

To evaluate the association of intensive blood pressure treatment with cerebral white matter lesion and brain volumes. Design, Setting, and

Participants:

A substudy of a multicenter randomized clinical trial of hypertensive adults 50 years or older without a history of diabetes or stroke at 27 sites in the United States. Randomization began on November 8, 2010. The overall trial was stopped early because of benefit for its primary outcome (a composite of cardiovascular events) and all-cause mortality on August 20, 2015. Brain magnetic resonance imaging (MRI) was performed on a subset of participants at baseline (n = 670) and at 4 years of follow-up (n = 449); final follow-up date was July 1, 2016.

Interventions:

Participants were randomized to a systolic blood pressure (SBP) goal of either less than 120 mm Hg (intensive treatment, n = 355) or less than 140 mm Hg (standard treatment, n = 315). Main Outcomes and

Measures:

The primary outcome was change in total white matter lesion volume from baseline. Change in total brain volume was a secondary outcome.

Results:

Among 670 recruited patients who had baseline MRI (mean age, 67.3 [SD, 8.2] years; 40.4% women), 449 (67.0%) completed the follow-up MRI at a median of 3.97 years after randomization, after a median intervention period of 3.40 years. In the intensive treatment group, based on a robust linear mixed model, mean white matter lesion volume increased from 4.57 to 5.49 cm3 (difference, 0.92 cm3 [95% CI, 0.69 to 1.14]) vs an increase from 4.40 to 5.85 cm3 (difference, 1.45 cm3 [95% CI, 1.21 to 1.70]) in the standard treatment group (between-group difference in change, -0.54 cm3 [95% CI, -0.87 to -0.20]). Mean total brain volume decreased from 1134.5 to 1104.0 cm3 (difference, -30.6 cm3 [95% CI, -32.3 to -28.8]) in the intensive treatment group vs a decrease from 1134.0 to 1107.1 cm3 (difference, -26.9 cm3 [95% CI, 24.8 to 28.8]) in the standard treatment group (between-group difference in change, -3.7 cm3 [95% CI, -6.3 to -1.1]). Conclusions and Relevance Among hypertensive adults, targeting an SBP of less than 120 mm Hg, compared with less than 140 mm Hg, was significantly associated with a smaller increase in cerebral white matter lesion volume and a greater decrease in total brain volume, although the differences were small. Trial Registration ClinicalTrials.gov Identifier NCT01206062.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Encéfalo / Sustancia Blanca / Hipertensión / Antihipertensivos Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Encéfalo / Sustancia Blanca / Hipertensión / Antihipertensivos Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article